Scientific consultation on immunological correlates of protection induced by dengue vaccines. Report from a meeting held at the World Health Organization 17-18 November 2005

Vaccine

Volumn 25, Issue 21, 2007, Pages 4130-4139

  Hombach, Joachim ^a   Jane Cardosa, M ^b   Sabchareon, Arunee ^c   Vaughn, David W ^d   Barrett, Alan D T ^e  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITI MALAYSIA SARAWAK   (Malaysia)

^c MAHIDOL UNIVERSITY   (Thailand)

^d U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

^e University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Correlates; Dengue; Immunity; Vaccine

Indexed keywords

DENGUE VACCINE; ENCEPHALITIS VACCINE; UNCLASSIFIED DRUG; VAXFECTIN; VIRUS VACCINE;

CONFERENCE PAPER; CONSULTATION; CORRELATION ANALYSIS; DENGUE; DENGUE VIRUS; ENCEPHALOMYELITIS; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIREMIA; WORLD HEALTH ORGANIZATION;

BIOLOGICAL MARKERS; DENGUE; DENGUE VACCINES; HUMANS;

EID: 34247337264     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.02.079     Document Type: Conference Paper

References (23)

1. Plotkin S.A. Immunologic correlates of protection induced by vaccination. Pediatr Infect Dis J 20 1 (2001) 63-75
2. Libraty D.H., Endy T.P., Houng H.S., Green S., Kalayanarooj S., Suntayakorn S., et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 185 9 (2002) 1213-1221
3. Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitya S., Suntayakorn S., et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181 1 (2000) 2-9
4. Green S., Vaughn D.W., Kalayanarooj S., Nimmannitya S., Suntayakorn S., Nisalak A., et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 179 4 (1999) 755-762
5. Endy T.P., Nisalak A., Chunsuttitwat S., Vaughn D.W., Green S., Ennis F.A., et al. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis 189 6 (2004) 990-1000
6. Mangada M.M., Endy T.P., Nisalak A., Chunsuttiwat S., Vaughn D.W., Libraty D.H., et al. Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai school children. J Infect Dis 185 12 (2002) 1697-1703
7. Sabchareon A., Lang J., Chanthavanich P., Yoksan S., Forrat R., Attanath P., et al. Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adults volunteers: role of serotype concentration, ratio, and multiple doses. Am J Trop Med Hyg 66 3 (2002) 264-272
8. Sabchareon A., Lang J., Chanthavanich P., Yoksan S., Forrat R., Attanath P., et al. Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children. Pediatr Infect Dis J 23 2 (2004) 99-109
9. Guzman M.G., Kouri G.P., Bravo J., Soler M., Vazquez S., and Morier L. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg 42 2 (1990) 179-184
10. Shresta S., Kyle J.L., Snider H.M., Basavapatna M., Beatty P.R., and Harris E. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol 78 6 (2004) 2701-2710
11. Shresta S., Sharar K.L., Prigozhin D.M., Snider H.M., Beatty P.R., and Harris E. Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J Immunol 175 6 (2005) 3946-3954
12. Halstead S.B., Casals J., Shotwell H., and Palumbo N. Studies on the immunization of monkeys against dengue. I. Protection derived from single and sequential virus infections. Am J Trop Med Hyg 22 3 (1973) 365-374
13. Sun W., Nisalak A., Gettayacamin M., Eckels K.H., Putnak J.R., Vaughn D.W., et al. Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination. J Infect Dis 193 12 (2006) 1658-1665
14. Edelman R., Wasserman S.S., Bodison S.A., Putnak R.J., Eckels K.H., Tang D., et al. Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine. Am J Trop Med Hyg 69 Suppl. 6 (2003) 48-60
15. Modis Y., Ogata S., Clements D., and Harrison S.C. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J Virol 79 2 (2005) 1223-1231
16. Modis Y., Ogata S., Clements D., and Harrison S.C. Structure of the dengue virus envelope protein after membrane fusion. Nature 427 6972 (2004) 313-319
17. Goncalvez A.P., Purcell R.H., and Lai C.J. Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein. J Virol 78 23 (2004) 12919-12928
18. Tan C.H., Yap E.H., Singh M., Deubel V., and Chan Y.C. Passive protection studies in mice with monoclonal antibodies directed against the non-structural protein NS3 of dengue 1 virus. J Gen Virol 71 Part 3 (1990) 745-749
19. Mangada M.M., and Rothman A.L. Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. J Immunol 175 4 (2005) 2676-2683
20. Mongkolsapaya J., Dejnirattisai W., Xu X.N., Vasanawathana S., Tangthawornchaikul N., Chairunsri A., et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9 7 (2003) 921-927
21. Halstead S.B., Rojanasuphot S., and Sangkawibha N. Original antigenic sin in dengue. Am J Trop Med Hyg 32 1 (1983) 154-156
22. Kuno G., Gubler D.J., and Oliver A. Use of 'original antigenic sin' theory to determine the serotypes of previous dengue infections. Trans R Soc Trop Med Hyg 87 1 (1993) 103-105
23. Guirakhoo F., Pugachev K., Arroyo J., Miller C., Zhang Z.X., Weltzin R., et al. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates. Virology 298 1 (2002) 146-159